Acurx Pharmaceuticals (ACXP) SEC Filings: History & Chart

Acurx Pharmaceuticals, Inc.(ACXP)

Biotechnology · Staten Island, NY

$1.29-0.02 (-1.33%)

Delayed quote: Oct 6, 2026, 3:51 PM EDT

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and penicillin-resistant Streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was established in 2017 and is headquartered in Staten Island, New York.

Staten Island, NY

4 employees

www.acurxpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Luci

View full financials

Form	Filing Date	Accepted	Document
EFFECT	Sep 17, 2026	Sep 18, 2026	View filing
424B3	Sep 17, 2026	Sep 17, 2026	View filing
S-1	Sep 8, 2026	Sep 8, 2026	View filing
ARS	Sep 1, 2026	Sep 1, 2026	View filing
DEFA14A	Sep 1, 2026	Sep 1, 2026	View filing
DEF 14A	Sep 1, 2026	Sep 1, 2026	View filing
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
424B3	May 12, 2026	May 12, 2026	View filing
424B3	May 12, 2026	May 12, 2026	View filing
EFFECT	May 11, 2026	May 12, 2026	View filing
EFFECT	May 11, 2026	May 12, 2026	View filing
10-Q	May 11, 2026	May 11, 2026	View filing
S-1	May 4, 2026	May 4, 2026	View filing
S-1	May 4, 2026	May 4, 2026	View filing
D	Apr 29, 2026	Apr 29, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
4	Apr 22, 2026	Apr 22, 2026	View filing
8-K	Apr 16, 2026	Apr 16, 2026	View filing
424B5	Apr 16, 2026	Apr 16, 2026	View filing
S-8	Mar 12, 2026	Mar 12, 2026	View filing
10-K	Mar 12, 2026	Mar 12, 2026	View filing
8-K	Mar 9, 2026	Mar 9, 2026	View filing
EFFECT	Feb 11, 2026	Feb 12, 2026	View filing
424B3	Feb 11, 2026	Feb 11, 2026	View filing

SEC Filings

Recent Filings